Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Mesenchymal stem cells attenuate vascular remodeling in monocrotaline-induced pulmonary hypertension rats.

Xie J, Hu D, Niu L, Qu S, Wang S, Liu S.

J Huazhong Univ Sci Technolog Med Sci. 2012 Dec;32(6):810-7. doi: 10.1007/s11596-012-1039-x. Epub 2012 Dec 28.

PMID:
23271278
2.

Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension.

Kanki-Horimoto S, Horimoto H, Mieno S, Kishida K, Watanabe F, Furuya E, Katsumata T.

Circulation. 2006 Jul 4;114(1 Suppl):I181-5.

3.

Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice.

Aliotta JM, Pereira M, Wen S, Dooner MS, Del Tatto M, Papa E, Goldberg LR, Baird GL, Ventetuolo CE, Quesenberry PJ, Klinger JR.

Cardiovasc Res. 2016 Jun 1;110(3):319-30. doi: 10.1093/cvr/cvw054. Epub 2016 Mar 14.

4.

Implantation of mesenchymal stem cells improves right ventricular impairments caused by experimental pulmonary hypertension.

Luan Y, Zhang ZH, Wei DE, Zhao JJ, Kong F, Cheng GH, Wang YB.

Am J Med Sci. 2012 May;343(5):402-6. doi: 10.1097/MAJ.0b013e31822dc5d3.

PMID:
21876426
5.

Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.

Yang PS, Kim DH, Lee YJ, Lee SE, Kang WJ, Chang HJ, Shin JS.

Respir Res. 2014 Nov 25;15:148. doi: 10.1186/s12931-014-0148-4. Erratum in: Respir Res. 2016 Nov 4;17 (1):142.

6.

Adipose-derived stem cells attenuate pulmonary arterial hypertension and ameliorate pulmonary arterial remodeling in monocrotaline-induced pulmonary hypertensive rats.

Luo L, Lin T, Zheng S, Xie Z, Chen M, Lian G, Xu C, Wang H, Xie L.

Clin Exp Hypertens. 2015;37(3):241-8. doi: 10.3109/10641963.2014.954710. Epub 2014 Oct 1.

PMID:
25271670
8.
9.
10.

The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats.

Lee H, Lee JC, Kwon JH, Kim KC, Cho MS, Yang YS, Oh W, Choi SJ, Seo ES, Lee SJ, Wang TJ, Hong YM.

J Korean Med Sci. 2015 May;30(5):576-85. doi: 10.3346/jkms.2015.30.5.576. Epub 2015 Apr 15.

11.

[Effect of sesamin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary hypertension].

Li XW, Gao YX, Li S, Yang JR.

Zhongguo Zhong Yao Za Zhi. 2015 Apr;40(7):1355-61. Chinese.

PMID:
26281561
12.

Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.

Mei Y, Jin H, Tian W, Wang H, Wang H, Zhao Y, Zhang Z, Meng F.

Pulm Pharmacol Ther. 2011 Aug;24(4):386-93. doi: 10.1016/j.pupt.2011.03.003. Epub 2011 Mar 15.

PMID:
21396478
13.

Salvianolic acid A attenuates vascular remodeling in a pulmonary arterial hypertension rat model.

Chen YC, Yuan TY, Zhang HF, Wang DS, Yan Y, Niu ZR, Lin YH, Fang LH, Du GH.

Acta Pharmacol Sin. 2016 Jun;37(6):772-82. doi: 10.1038/aps.2016.22. Epub 2016 May 16.

14.

Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.

Tofovic SP, Salah EM, Mady HH, Jackson EK, Melhem MF.

J Cardiovasc Pharmacol. 2005 Oct;46(4):430-7.

PMID:
16160593
15.

Monocrotaline-Induced Pulmonary Hypertension Involves Downregulation of Antiaging Protein Klotho and eNOS Activity.

Varshney R, Ali Q, Wu C, Sun Z.

Hypertension. 2016 Nov;68(5):1255-1263. Epub 2016 Sep 26.

16.

The synergistic therapeutic effect of hepatocyte growth factor and granulocyte colony-stimulating factor on pulmonary hypertension in rats.

Guo Y, Su L, Li Y, Guo N, Xie L, Zhang D, Zhang X, Li H, Zhang G, Wang Y, Liu C.

Heart Vessels. 2014 Jul;29(4):520-31. doi: 10.1007/s00380-013-0395-1. Epub 2013 Aug 10.

PMID:
23933910
17.

Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.

Paffett ML, Lucas SN, Campen MJ.

Vascul Pharmacol. 2012 Jan-Feb;56(1-2):64-73. doi: 10.1016/j.vph.2011.11.002. Epub 2011 Nov 25.

18.

Characterization of erectile function in monocrotaline-treated pulmonary hypertensive rats.

Gur S, Kadowitz PJ, Thammasitboon S, Lasky JA, Hellstrom WJ.

J Androl. 2009 Sep-Oct;30(5):495-504. doi: 10.2164/jandrol.108.006700. Epub 2009 Feb 5.

19.

2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.

Tofovic SP, Zhang X, Jackson EK, Dacic S, Petrusevska G.

Vascul Pharmacol. 2006 Dec;45(6):358-67. Epub 2006 Jun 8.

PMID:
16872912
20.

Supplemental Content

Support Center